Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi
Yıl: 2021 Cilt: 49 Sayı: 1 Sayfa Aralığı: 108 - 114 Metin Dili: Türkçe DOI: 10.33076/2021.BDD.1426 İndeks Tarihi: 28-09-2021
Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi
Öz: Sarkopeni, kas yapısında olumsuz değişikliklerin meydana gelmesiyle gelişen, genellikle ileri yaş grubunda yaygın olmaklaberaber yaşamın erken dönemlerinde de görülebilen bir kas hastalığıdır. Dünyada olduğu gibi Türkiye’de de görülmedurumu yaygındır. Sarkopeni, tedavi edilmediği takdirde çeşitli bireysel, sosyal ve ekonomik yükler oluşturmaktadır. Bunedenle erken tanı ve gerekli tedavi önem arz etmektedir. Beslenme tedavisi, sarkopeni tedavisinin önemli bileşenlerindenbiridir. Bireylerin beslenme durumunun düzenlenmesi sarkopeniyi önleme, olumsuz sonuçlarını engelleme veya geciktirmeaçısından önemli katkılar sağlamaktadır. Özellikle diyet ile besin alımının yetersiz olduğu durumlarda beslenme destektedavisinin klinik sonuçlar üzerine olumlu etkisi olduğu bilinmektedir. Bu makalede, sarkopenik bir olguda beslenmedestek tedavisi ve izlemi tartışılmıştır
Anahtar Kelime: A Case with Sarcopenia: Monitoring of the Nutritional Support Therapy
Öz: Sarcopenia is a muscle disease rooted in adverse muscle changes in muscle structure and is generally seen in the elderly, but also seen in the early stages of life. It is a common condition seen in Turkey like all over the world. If it is not treated, creates various individual, social and economic burdens. Therefore, early diagnosis and treatment are important. Nutritional therapy is an important component of sarcopenia treatment. Regulation of the nutritional status of individuals makes important contributions in terms of preventing sarcopenia or delaying its negative consequences. It is known that nutritional support therapy has positive effect on clinical outcomes, especially in cases where dietary intake is sufficient. In this article, nutritional support treatment and follow-up in a sarcopenic case was discussed.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in older people. Age Ageing. 2010;39(4):412-12.
- 2. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-15.
- 3. Peixoto da Silva S, Santos JM, Costa e Silva MP, Gil da Costa RM, Medeiros R. Cancer cachexia and its pathophysiology: Links with sarcopenia, anorexia and asthenia. J Cachexia, Sarcopenia Muscle. 2020;11:619-16.
- 4. Halil M, Ulger Z, Varlı M, Döventaş A, Oztürk G, Kuyumcu M, et al. Sarcopenia assessment project in the nursing homes in Turkey. Eur J Clin Nutr. 2014;68(6):690-4.
- 5. Bahat G, Ilhan B. Sarcopenia and the cardiometabolic syndrome: A narrative review. Eur Geriatr Med. 2016;7(3):220-3.
- 6. Antunes AC, Araújo DA, Veríssimo MT, Amaral TF. Sarcopenia and hospitalisation costs in older adults: A cross‐sectional study. Nutr Diet. 2017;74(1):46-5.
- 7. Rijk JM, Roos PR, Deckx L, Van den Akker M, Buntinx F. Prognostic value of handgrip strength in people aged 60 years and older: a systematic review and meta-analysis. Geriatr Gerontol Int. 2016;16(1):5-15.
- 8. Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, et al. Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper from the PROT-AGE Study Group. JAMDA. 2013;14(8):542-17. Muir SW, Montero-Odasso M. Effect of D vitamin supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2011;59:2291-10.
- 9. Pekcan G, Beslenme durumunun saptanması. Baysal A, Aksoy M, Besler T, Bozkurt N, Keçecioğlu S, Kutluay Merdol T ve ark, editörler, Diyet El Kitabı. 5. Baskı. Ankara: Hatiboğlu Yayınları; 2008. s. 67-75
- 10. Kondrup J, Rasmussen HH, Hamberg OLE, Stanga Z, & An ad hoc ESPEN Working Group. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22(3):321-15.
- 11. Arends J, Bachman P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11-37
- 12. Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G, et al. ESPEN guidelines on enteral nutrition: Non-surgical oncology. Clin Nutr. 2006;25(2):245-14.
- 13. Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, BosyWestphal A, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin Nutr. 2014;33(6):929-7.
- 14. Rondanelli M, Faliva M, Monteferrario F, Peroni G, Repaci E, Allieri F, et al. Novel insights on nutrient management of sarcopenia in elderly. Biomed Res Int. 2015;2015:524948.
- 15. Yoshimura Y, Bise T, Shimazu S, Tanoue M, Tomiako Y, Araki M, et al. Effect of a leucine-enriched amino asit supplement on muscle mass, muscle strength, and physical function in post stroke patients with sarcopenia: A randomized controlled trial. Nutr. 201958:1-6.
- 16. Holecek M. Beta-hydroxy-beta-methylbutyrate supplementation ond skeletal in healthy and musclewasting conditions. J Cachexia Sarcopenia Muscle. 2017;8(4):529-12.
- 17. Din USU, Brook MS, Selby A, Quinlan J, Boereboom C, Abdulla H, et al. A double-blind placebo controlled trial into the impacts of HMB supplementation and exercise on free-living muscle protein synthesis, muscle mass and function, in older adults. Clin Nutr. 2019;38(5):2071- 8.
- 18. Apaydın M, Gencay Can A, Kizilgul M, Beysel S, Kan S, Caliskan M, et al. The effects of single high-dose or daily low-dosage oral colecalciferol treatment on vitamin D levels and muscle strength in postmenopausal women. BMC Endocrine Disorders. 2018;18(1):1-6.
- 19. Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr. 2019;38(1):10-37.
| APA | Toprak K, ergil j (2021). Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi. , 108 - 114. 10.33076/2021.BDD.1426 |
| Chicago | Toprak Kadriye,ergil julide Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi. (2021): 108 - 114. 10.33076/2021.BDD.1426 |
| MLA | Toprak Kadriye,ergil julide Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi. , 2021, ss.108 - 114. 10.33076/2021.BDD.1426 |
| AMA | Toprak K,ergil j Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi. . 2021; 108 - 114. 10.33076/2021.BDD.1426 |
| Vancouver | Toprak K,ergil j Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi. . 2021; 108 - 114. 10.33076/2021.BDD.1426 |
| IEEE | Toprak K,ergil j "Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi." , ss.108 - 114, 2021. 10.33076/2021.BDD.1426 |
| ISNAD | Toprak, Kadriye - ergil, julide. "Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi". (2021), 108-114. https://doi.org/10.33076/2021.BDD.1426 |
| APA | Toprak K, ergil j (2021). Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi. Beslenme ve Diyet Dergisi, 49(1), 108 - 114. 10.33076/2021.BDD.1426 |
| Chicago | Toprak Kadriye,ergil julide Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi. Beslenme ve Diyet Dergisi 49, no.1 (2021): 108 - 114. 10.33076/2021.BDD.1426 |
| MLA | Toprak Kadriye,ergil julide Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi. Beslenme ve Diyet Dergisi, vol.49, no.1, 2021, ss.108 - 114. 10.33076/2021.BDD.1426 |
| AMA | Toprak K,ergil j Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi. Beslenme ve Diyet Dergisi. 2021; 49(1): 108 - 114. 10.33076/2021.BDD.1426 |
| Vancouver | Toprak K,ergil j Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi. Beslenme ve Diyet Dergisi. 2021; 49(1): 108 - 114. 10.33076/2021.BDD.1426 |
| IEEE | Toprak K,ergil j "Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi." Beslenme ve Diyet Dergisi, 49, ss.108 - 114, 2021. 10.33076/2021.BDD.1426 |
| ISNAD | Toprak, Kadriye - ergil, julide. "Sarkopenik Olgu: Beslenme Destek Tedavisinin İzlemi". Beslenme ve Diyet Dergisi 49/1 (2021), 108-114. https://doi.org/10.33076/2021.BDD.1426 |
